Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion type Assertion NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_head.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion wasGeneratedBy ECO_0000203 NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_provenance.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion wasDerivedFrom befree-2016 NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_provenance.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion SIO_000772 22351748 NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_provenance.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion evidence source_evidence_literature NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_provenance.
- NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_assertion description "[Only 5 (23.8%) of the 21 HER2-positive breast tumors showed cdr2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962305.RADVpJ1XAa69OkJ7k4-bgjDhC0Ajl2C8gNYeZkmwEK_vA130_provenance.